课题基金基金详情
IgA血管炎肾损害中FCAR基因调控区遗传变异致内皮细胞损伤的分子机制研究
结题报告
批准号:
81970598
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
朱厉
依托单位:
学科分类:
继发性肾脏疾病
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
朱厉
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
客服二维码
微信扫码咨询
中文摘要
IgA血管炎(IgAV)是IgA小血管壁沉积为特征性表现的系统性血管炎,累及肾脏为IgA血管炎肾损害(IgAVN)。成人IgAV肾脏受累率高,预后不良。申请者前期成人IgAVN的全基因组关联分析(GWAS)发现FCAR调控区遗传变异与IgAVN发病相关,还与肾小球毛细血管壁IgA沉积、内皮增生病变相关。FCAR编码IgA Fc受体(FcαR),主要表达在中性粒细胞表面,被证实与IgA复合物结合并促进中性粒细胞活化并与内皮细胞粘附。因此申请者提出科学假设:FCAR调控区危险型遗传变异上调中性粒细胞FcαR表达并与致病性IgA复合物结合,致中性粒细胞活化,促内皮细胞粘附,导致IgAVN中IgA血管壁沉积和内皮细胞损伤。本研究拟探讨FCAR调控区遗传变异影响FcαR表达的机制;并检测FCAR基因型对中性粒细胞结合致病IgA复合物、损伤内皮细胞的影响,明确FCAR参与IgAVN发病的分子遗传机制。
英文摘要
IgA vasculitis (IgAV) is a systemic vasculitis with IgA-dominant immune deposits, affecting small vessels. IgAV patients with nephritis are called IgAVN. Adult IgAV patients have more frequent renal involvement and poor prognosis. We previously performed a genome-wide association study in adult IgAVN patients and identified FCAR as an IgAVN susceptible gene. In addition, regulatory variants in FCAR were found to be associated with the phenotype of IgA deposits on the glomerular capillary walls, as well as glomerular endothelial cells proliferation. FCAR gene encodes a receptor for the Fc region of IgA (FcαR), which is a transmembrane glycoprotein present on the surface of myeloid lineage cells, mainly neutrophils. It has been proved that multimeric IgA immune complexes trigger several activation responses in neutrophils after binding to FcaRI, including acceleration its adherence to endothelial cells. Based on these clues, we proposed the following pathogenic hypothesis for IgAVN: the regulatory risk variants in FCAR gene up-regulate the expression of FcαR on the surface of neutrophils; after binding with its ligand IgA complex, FcαR would induce the activation of neutrophils, and facilitate its adherence to endothelial cells, which results in IgA deposits on the glomerular capillary walls and glomerular endothelial cells proliferation in IgAVN. In the present research project, we plan to investigate the mechanism of variants in FCAR regarding its regulation to FcαR expression, as well as its influence to IgA small vessels deposition and endothelial cells injury in IgAVN.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10.1093/ckj/sfac214
发表时间:2023-01
期刊:Clinical kidney journal
影响因子:4.6
作者:
通讯作者:
Neutrophil-to-lymphocyte ratio as an independent inflammatory indicator for poor renal prognosis in adult IgA vasculitis with nephritis.
中性粒细胞与淋巴细胞比率作为成人 IgA 血管炎肾炎肾预后不良的独立炎症指标。
DOI:10.1016/j.intimp.2022.109178
发表时间:2022
期刊:International immunopharmacology
影响因子:5.6
作者:Qianqian Li;S. Shi;Lijun Liu;J. Lv;Li Zhu;Hong Zhang
通讯作者:Hong Zhang
DOI:10.1016/j.intimp.2020.106811
发表时间:2020-10-01
期刊:INTERNATIONAL IMMUNOPHARMACOLOGY
影响因子:5.6
作者:Li, Qianqian;Chen, Ping;Zhang, Hong
通讯作者:Zhang, Hong
IgA肾病中CFHR1介导肾小球炎症损伤的机制研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    朱厉
  • 依托单位:
CFHR1基因编码区遗传变异调控IgA肾病补体活化的机制研究
  • 批准号:
    81670638
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    朱厉
  • 依托单位:
髓系细胞触发受体-1在IgA肾病中介导肾脏损伤的作用机制研究
  • 批准号:
    81470945
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    朱厉
  • 依托单位:
糖基化异常的IgA1分子在IgA肾病中致足细胞损伤的机制研究
  • 批准号:
    81000297
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2010
  • 负责人:
    朱厉
  • 依托单位:
国内基金
海外基金